Rein Therapeutics, Inc. Stock Issued During Period, Value, New Issues
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- Rein Therapeutics, Inc. stock issued during period, value, new issues for the quarter ending 2026-06-30 was $49.83M, a 150903.03% increase year-over-year.
- Rein Therapeutics, Inc. stock issued during period, value, new issues for the quarter ending 2026-03-31 was $355.00K, a 51.90% decline year-over-year.
- Rein Therapeutics, Inc. stock issued during period, value, new issues for the quarter ending 2025-06-30 was $33.00K, a 99.70% decline year-over-year.
- Rein Therapeutics, Inc. stock issued during period, value, new issues for the quarter ending 2025-03-31 was $738.00K.
- Rein Therapeutics, Inc. stock issued during period, value, new issues for fiscal 2024 was $10.94M.
- Rein Therapeutics, Inc. stock issued during period, value, new issues for fiscal 2021 was $59.09M, a 249.70% increase from fiscal 2020.
- Rein Therapeutics, Inc. stock issued during period, value, new issues for fiscal 2020 was $16.90M.
- Rein Therapeutics, Inc. stock issued during period, value, new issues for fiscal 2017 was $50.01M.
| Period end | Stock Issued During Period, Value, New Issues 3 month | Stock Issued During Period, Value, New Issues 12 month |
|---|---|---|
| 2026-06-30 | $49.83M 10-Q · filed 2026-08-14 | |
| 2026-03-31 | $355.00K 10-Q · filed 2026-08-14 | |
| 2025-06-30 | $33.00K 10-Q · filed 2026-08-14 | |
| 2025-03-31 | $738.00K 10-Q · filed 2026-08-14 | |
| 2024-12-31 | $10.94M 10-K · filed 2026-03-26 | |
| 2024-06-30 | $10.94M 10-Q · filed 2025-11-14 | |
| 2021-12-31 | $59.09M 10-K · filed 2023-03-20 | |
| 2021-03-31 | $59.09M 10-Q · filed 2022-11-01 | |
| 2020-12-31 | $16.90M 10-K · filed 2022-03-28 | |
| 2020-09-30 | $364.00K 10-Q · filed 2021-11-12 | |
| 2020-06-30 | $11.91M 10-Q · filed 2021-11-12 | |
| 2017-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-29 | $50.01M 10-K · filed 2019-03-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| HYPERION DEFI, INC. (HYPD) | United States | $0.065B | |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| Skye Bioscience, Inc. (SKYE) | United States | $0.061B | -0.48 |
| CalciMedica, Inc. (CALC) | United States | $0.061B | -1.42 |
| TALPHERA, INC. (TLPH) | United States | $0.060B | |
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| NOMAD POWER SOLUTIONS, INC. (NMAD) | United States | $0.058B | |
| Connect Biopharma Holdings Ltd (CNTB) | $0.069B | -2.17 | |
| Yarrow Bioscience, Inc. (YARW) | United States | $0.070B | |
| Annovis Bio, Inc. (ANVS) | United States | $0.056B | -1.58 |